Announcement on Subsidiary Receiving Approval Notice for Marketing Application of Chemical Active Pharmaceutical Ingredient
· Issued by Zhejiang Medicine Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary Receiving Approval Notice for Marketing Application of Chemical Active Pharmaceutical Ingredient
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment